Noticias de CRL_US

Mercado

Noticias del mercado

Últimas noticias sobre CRL_US — 264 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CRL_US ✕ 264 resultados
24/10/2026 CRL_US — Simply Wall Street ES ← EN
¿La asociación de pruebas de medicamentos de la FDA cambia el argumento de las acciones de Charles River Labs?

Labcorp anunció recientemente una colaboración con la FDA y Charles River Laboratories para desarrollar herramientas armonizadas de economía del comportamiento que cuantifiquen un medicamento.

23/10/2026 CRL_US — MarketWatch ES ← EN
Las acciones de Charles River Laboratories International Inc. superan a sus competidores en un día de negociación fuerte

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day

22/10/2026 CRL_US — Stock Titan ES ← EN
La FDA está trabajando con Charles River y Labcorp en herramientas para detectar riesgos de abuso en nuevos medicamentos.

Charles River ha realizado más de 100 estudios de potencial abuso y utilizará modelos económicos conductuales para analizar datos de autoadministración.

22/10/2026 CRL_US — Yahoo Finance ES ← EN
Precio, noticias, cotización e historial de acciones de Charles River Laboratories International, Inc. (CRL)

Charles River Laboratories International, Inc. (CRL) stock price, news, quote and history

21/10/2026 CRL_US — Timothy Sykes
Charles River (CRL) Stock Charges Higher On Bullish Targets And AI Hype

Charles River Laboratories International Inc. stocks have been trading up by 11.27 percent amid strong earnings and optimistic growth outlook. Key Takeaways For CRL Traders Street turned sharply bullish after CRL’s 2026 Investor Day, with long-term growth, margin, and EPS targets laid out to 2030

21/10/2026 CRL_US — StocksToTrade
Charles River Labs Stock Climbs As Analysts Boost Targets

Charles River Laboratories International Inc. stocks have been trading up by 11.27 percent amid strong earnings-driven investor optimism. Key Takeaways Traders Need To Know Management’s refreshed “Pathway to Purpose” plan targets 5–7% organic revenue growth from 2027–2030, margin expansion toward 24%, and low double-digit EPS gains, backed by over $300M in expected cost savings. A…

21/10/2026 CRL_US — Stock Titan
An officer proposes selling 2,156 Charles River (CRL) shares acquired by exercising stock options.

Shannon M. Parisotto nombró a UBS Financial Services para la venta propuesta alrededor del 21 de octubre de 2026. El aviso enumera cuatro ventas en los tres meses anteriores.

21/10/2026 CRL_US — StocksToTrade
Charles River Labs Stock Jumps As Street Hikes Targets

Charles River Laboratories International Inc. stocks have been trading up by 8.39 percent following strong earnings and upbeat guidance. Key Takeaways Traders Need To Know Street enthusiasm around CRL surged after its 2026 investor day, with management rolling out the “Pathway to Purpose” plan and locking in ambitious revenue, margin, and EPS growth goals into…

21/10/2026 CRL_US — Timothy Sykes
Charles River (CRL) Stock Climbs As Wall Street Turns Bullish

Charles River Laboratories International Inc. surged as animal-testing regulatory relief fueled optimism, and its stocks have been trading up by 8.5 percent. Key Takeaways For CRL Traders Management’s new “Pathway to Purpose” plan targets 5–7% organic revenue growth from 2027–2030, margin expansion

21/10/2026 CRL_US — Yahoo Finance ES ← EN
Charles River Laboratories International, Inc. (CRL) Precio de acciones, noticias, cotización e historial

Find the latest Charles River Laboratories International, Inc. (CRL) stock quote, history, news and other vital information to help you with your stock trading and investing.

21/10/2026 CRL_US — Yahoo Finance ES ← EN
Precio, noticias, cotización e historial de acciones de Charles River Laboratories International, Inc. (CRL)

Find the latest Charles River Laboratories International, Inc. (CRL) stock quote, history, news and other vital information to help you with your stock trading and investing.

Página 1 de 14